Thrivent Financial For Lutherans Travere Therapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$15.3 - $22.61 $1.41 Million - $2.09 Million
-92,384 Reduced 35.06%
171,115 $2.63 Million
Q1 2023

May 17, 2023
BUY
$17.82 - $22.89 $1.7 Million - $2.19 Million
95,562 Added 56.9%
263,499 $5.93 Million
Q4 2022

Feb 08, 2023
BUY
$18.47 - $26.14 $44,383 - $62,814
2,403 Added 1.45%
167,937 $3.53 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $228,183 - $285,154
9,960 Added 6.4%
165,534 $4.08 Million
Q2 2022

Aug 16, 2022
SELL
$20.94 - $30.01 $579,598 - $830,646
-27,679 Reduced 15.1%
155,574 $3.77 Million
Q1 2022

May 13, 2022
SELL
$23.61 - $30.6 $4,415 - $5,722
-187 Reduced 0.1%
183,253 $4.72 Million
Q4 2021

Feb 16, 2022
SELL
$24.34 - $31.17 $1.93 Million - $2.47 Million
-79,352 Reduced 30.2%
183,440 $5.69 Million
Q3 2021

Nov 15, 2021
BUY
$12.98 - $25.03 $3.41 Million - $6.58 Million
262,792 New
262,792 $6.37 Million
Q2 2021

Aug 19, 2021
SELL
$14.11 - $26.4 $3.49 Million - $6.52 Million
-247,011 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $1.93 Million - $2.63 Million
82,628 Added 50.27%
247,011 $6.17 Million
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $3.15 Million - $4.58 Million
164,383 New
164,383 $4.48 Million

Others Institutions Holding TVTX

# of Institutions
192
Shares Held
84.5M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email